Cargando…
Linezolid-resistant Mycobacterium tuberculosis: Will it impact the tuberculosis elimination programme?
Autor principal: | Bharadwaj, Renu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715697/ https://www.ncbi.nlm.nih.gov/pubmed/34782525 http://dx.doi.org/10.4103/ijmr.IJMR_3537_20 |
Ejemplares similares
-
Linezolid for Treating Tuberculosis: A Delicate Balancing Act
por: Maartens, Gary, et al.
Publicado: (2015) -
Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid
por: Shah, Maunank, et al.
Publicado: (2020) -
Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis
por: Azimi, Taher, et al.
Publicado: (2022) -
Linezolid for drug‐resistant pulmonary tuberculosis
por: Singh, Bhagteshwar, et al.
Publicado: (2019) -
Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India
por: Nambiar, Remya, et al.
Publicado: (2021)